Author(s): Rawan H. Alsharedeh, Nida Alshraiedeh, Rawan Huwaitat, Mamduh Alqatan, Esra' O. Taybeh, Amjad Z. Alrosan, Ghaith B. Heilat

Email(s): r.sharedeh@yu.edu.jo

DOI: 10.52711/0974-360X.2022.00692   

Address: Rawan H. Alsharedeh1*, Nida Alshraiedeh2, Rawan Huwaitat3, Mamduh Alqatan4, Esra' O. Taybeh5, Amjad Z. Alrosan6, Ghaith B. Heilat7
1Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Irbid, Jordan.
2Department of Pharmaceutical Technology, Jordan University of Science and Technology, Irbid, Jordan.
3Faculty of Pharmacy, Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
4Al Mafraq Hospital, Mafraq, Jordan.
5Faculty of Pharmacy, Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Isra University, Amman, Jordan.
6Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacy Practice, Hashemite University, Irbid, Jordan.
7Faculty of Medicine, Department of Clinical Medical Sciences, Yarmouk University, Irbid, Jordan.
*Corresponding Author

Published In:   Volume - 15,      Issue - 9,     Year - 2022


ABSTRACT:
This study aims to assess and evaluate the knowledge, beliefs, behaviors, and practices about COVID-19 among different categories of Jordanian people including pregnant and breastfeeding mothers. A cross-sectional study is designed using an online survey questionnaire and a five-section questionnaire was devised to address perceptions and attitudes of the participants towards COVID-19. This study was found that more than 80% of the participants had a belief that COVID-19 can be transmitted through direct contact or spreading of air droplets from infected people to healthy ones. Around 15% of pregnant and breastfeeding women realized that the COVID-19 virus could transmit the virus to their babies. Third-fourth of the participants agreed that the elderly, pregnant, and immunocompromised people have a higher risk of being infected with COVID-19. In addition, 80% of the participants believed that using paracetamol is a good way of treating COVID-19 or reducing symptoms, while the remaining believed that they should use antibiotics as well as some vitamins to combat COVID-19. Around 70% of the participants have got their information about COVID-19 through social media while others got the information through the Jordanian Ministry of Health official website, other websites, television news, friends, relatives, and colleagues. Participants’ practices to avoid transmission of COVID-19 were adequate in more than 80% of the participants who reported that they should protect themselves as well as their families as a priority. we believe that this study allow other governments worldwide to understand the views of public people in Jordan during pandemic disease outbreaks.


Cite this article:
Rawan H. Alsharedeh, Nida Alshraiedeh, Rawan Huwaitat, Mamduh Alqatan, Esra' O. Taybeh, Amjad Z. Alrosan, Ghaith B. Heilat. Public perceptions of the COVID-19 Pandemic: A National Cross-sectional Study. Research Journal of Pharmacy and Technology. 2022; 15(9):4119-7. doi: 10.52711/0974-360X.2022.00692

Cite(Electronic):
Rawan H. Alsharedeh, Nida Alshraiedeh, Rawan Huwaitat, Mamduh Alqatan, Esra' O. Taybeh, Amjad Z. Alrosan, Ghaith B. Heilat. Public perceptions of the COVID-19 Pandemic: A National Cross-sectional Study. Research Journal of Pharmacy and Technology. 2022; 15(9):4119-7. doi: 10.52711/0974-360X.2022.00692   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-9-52


REFERENCES:
1.    Cai, J.; Sun, W.; Huang, J.; Gamber, M.; Wu, J.; He, G., Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerging infectious diseases 2020, 26 (6), 1343-1345.
2.    Cucinotta, D.; Vanelli, M., WHO declares COVID-19 a pandemic. Acta Bio Medica: Atenei Parmensis 2020, 91 (1), 157-160.
3.    WoM COVID-19 Coronavirus Pandemic. https://www.worldometers.info/coronavirus (accessed 26 Jan).
4.    Ji, H.-L.; Zhao, R.; Matalon, S.; Matthay, M. A., Elevated plasmin (ogen) as a common risk factor for COVID-19 susceptibility. Physiological reviews 2020, 1065-1075.
5.    (a) Rajnik, M.; Cascella, M.; Cuomo, A.; Dulebohn, S. C.; Di Napoli, R., Features, Evaluation, and Treatment of Coronavirus (COVID-19). In StatPearls [Internet], Treasure Island (FL): Florida, 2021; p 21; (b) Cui, J.; Li, F.; Shi, Z.-L., Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 2019, 17 (3), 181-192.
6.    Gostin, L. O.; Friedman, E. A.; Wetter, S. A., Responding to COVID-19: how to navigate a public health emergency legally and ethically. Hastings center report 2020, 50 (2), 8-12.
7.    Ong, E.; Wong, M. U.; Huffman, A.; He, Y., COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. Frontiers in immunology 2020, 11 (1581), 1-13.
8.    Silveira, D.; Prieto-Garcia, J. M.; Boylan, F.; Estrada, O.; Fonseca-Bazzo, Y. M.; Jamal, C. M.; Magalhães, P. O.; Pereira, E. O.; Tomczyk, M.; Heinrich, M., COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? Frontiers in Pharmacology 2020, 11 (581840), 1479.
9.    CDC Cleaning and Disinfecting Your Home. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/disinfecting-your-home.html (accessed 25 Jan).
10.    (a) Qeadan, F.; Mensah, N. A.; Tingey, B.; Stanford, J. B., The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC pregnancy and childbirth 2021, 21 (1), 1-14; (b) Wastnedge, E. A.; Reynolds, R. M.; Van Boeckel, S. R.; Stock, S. J.; Denison, F. C.; Maybin, J. A.; Critchley, H. O., Pregnancy and COVID-19. Physiological reviews 2021, 101 (1), 303-318.
11.    WHO Breastfeeding and COVID-19 For health care workers. https://apps.who.int/iris/bitstream/handle/10665/332719/WHO-2019-nCoV-FAQ-Breast_feeding-2020.1-eng.pdf.
12.    Parasher, A., COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgraduate Medical Journal 2021, 97 (1147), 312-320.
13.    Ahmad, S.; Shoaib, A.; Ali, M. S.; Alam, M. S.; Alam, N.; Ali, M.; Mujtaba, M. A.; Ahmad, A.; Ansari, M. S.; Ali, M. D., Epidemiology, risk, myths, pharmacotherapeutic management and socio economic burden due to novel COVID-19: A recent update. Research Journal of Pharmacy and Technology 2020, 13 (9), 4435-4442.
14.    Wu, J.; Liu, J.; Zhao, X.; Liu, C.; Wang, W.; Wang, D.; Xu, W.; Zhang, C.; Yu, J.; Jiang, B., Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clinical Infectious Diseases 2020, 71 (15), 706-712.
15.    Jones, N. R.; Qureshi, Z. U.; Temple, R. J.; Larwood, J. P.; Greenhalgh, T.; Bourouiba, L., Two metres or one: what is the evidence for physical distancing in covid-19? bmj 2020, 370 (3223), 1-6.
16.    Patil, P. A.; Jain, R. S., Theoretical Study and treatment of Novel COVID-19. Research journal of Pharmacology and Pharmacodynamics 2020, 12 (2), 71-72.
17.    Saber, S.; Khodir, A. E.; Maghmomeh, A. O.; Nouh, N. A.; El-Baz, A. M., COVID-19 Pandemic: current Challenges and future Perspectives. Research Journal of Pharmacy and Technology 2022, 15 (1), 329-337.
18.    Bai, Y.; Yao, L.; Wei, T.; Tian, F.; Jin, D.-Y.; Chen, L.; Wang, M., Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020, 323 (14), 1406-1407.
19.    (a) Pham, T. D.; Huang, C.; Wirz, O. F.; Röltgen, K.; Sahoo, M. K.; Layon, A.; Pandey, S.; Foung, S. K.; Boyd, S. D.; Pinsky, B. A., SARS-CoV-2 RNAemia in a healthy blood donor 40 days after respiratory illness resolution. Annals of Internal Medicine 2020, 173 (10), 853-854; (b) Owusu, M.; Sylverken, A. A.; El-Duah, P.; Ayisi-Boateng, N. K.; Yeboah, R.; Adu, E.; Asamoah, J.; Frimpong, M.; Senyo, J.; Acheampong, G., Low risk of SARS-CoV-2 in blood transfusion. Plos one 2021, 16 (4), e0249069.
20.    CDC Animals and COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/animals.html (accessed 25 Jan).
21.    Khasawneh, A. I.; Humeidan, A. A.; Alsulaiman, J. W.; Bloukh, S.; Ramadan, M.; Al-Shatanawi, T. N.; Awad, H. H.; Hijazi, W. Y.; Al-Kammash, K. R.; Obeidat, N., Medical students and COVID-19: knowledge, attitudes, and precautionary measures. A descriptive study from Jordan. Frontiers in public health 2020, 8 (253), 1-9.
22.    (a) Chen, H.; Guo, J.; Wang, C.; Luo, F.; Yu, X.; Zhang, W.; Li, J.; Zhao, D.; Xu, D.; Gong, Q., Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The lancet 2020, 395 (10226), 809-815; (b) Tolu, L. B.; Ezeh, A.; Feyissa, G. T., Vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A scoping review. Plos one 2021, 16 (4), e0250196.
23.    (a) Zambrano, L. D.; Ellington, S.; Strid, P.; Galang, R. R.; Oduyebo, T.; Tong, V. T.; Woodworth, K. R.; Nahabedian III, J. F.; Azziz-Baumgartner, E.; Gilboa, S. M., Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–October 3, 2020. Morbidity and Mortality Weekly Report 2020, 69 (44), 1641-1647; (b) Fung, M.; Babik, J. M., COVID-19 in immunocompromised hosts: what we know so far. Clinical Infectious Diseases 2021, 72 (2), 340-350.
24.    Singh, N., A Decisive Review to Understand the Basic Fundamentals of Novel Corona Viruse Disease. Research journal of Pharmacology and Pharmacodynamics 2021, 13 (4), 118-124.
25.    (a) Eldanasory, O. A.; Rabaan, A. A.; Al-Tawfiq, J. A., Can influenza vaccine modify COVID-19 clinical course? Travel Medicine and Infectious Disease 2020, 37 (101872), 1-2; (b) Conlon, A.; Ashur, C.; Washer, L.; Eagle, K. A.; Bowman, M. A. H., Impact of the influenza vaccine on COVID-19 infection rates and severity. American journal of infection control 2021, 49 (6), 694-700; (c) Taghioff, S. M.; Slavin, B. R.; Holton, T.; Singh, D., Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients. Plos one 2021, 16 (8), e0255541.
26.    Elayeh, E.; Akour, A.; Haddadin, R. N., Prevalence and predictors of self‐medication drugs to prevent or treat COVID‐19: Experience from a Middle Eastern country. International Journal of Clinical Practice 2021, 75 (11), e14860.
27.    Onchonga, D., A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharmaceutical Journal: SPJ 2020, 28 (7), 903–904.
28.    Jaber, R. M.; Mafrachi, B.; Al-Ani, A.; Shkara, M., Awareness and perception of COVID-19 among the general population: A Middle Eastern survey. Plos one 2021, 16 (4), e0250461.
29.    Aware, D.; Rohane, S., A role of herbal drug as an immunity booster during covid-19 pandemic. Asian Journal of Pharmaceutical Research 2021, 11 (3), 206-211.
30.    Patel, A. I.; Maru, P. R.; Patel, A. B.; Vyas, A. J.; Patel, N. K., Role of Vitamins, Minerals and Herbs in Strengthening immune system against the newly Emerging Viral Disease SARS-CoV-2. Asian Journal of Research in Pharmaceutical Science 2021, 11 (4).
31.    Mejia, C. R.; Ticona, D.; Rodriguez-Alarcon, J. F.; Campos-Urbina, A. M.; Catay-Medina, J. B.; Porta-Quinto, T.; Garayar-Peceros, H.; Ignacio-Quinte, C.; Esteban, R. F. C.; Mamani, P. G. R., The media and their informative role in the face of the coronavirus disease 2019 (COVID-19): validation of fear perception and magnitude of the issue (MED-COVID-19). Electronic Journal of General Medicine 2020, 17 (6), em239.
32.    FBSCH, S. M.; Bhagat, V., Review of the impact Covid-19 has on the Psychosocial factors affecting Well-Being. Research Journal of Pharmacy and Technology 2021, 14 (6), 3404-3408.
33.    (a) Fofana, N. K.; Latif, F.; Sarfraz, S.; Bashir, M. F.; Komal, B., Fear and agony of the pandemic leading to stress and mental illness: an emerging crisis in the novel coronavirus (COVID-19) outbreak. Psychiatry Research 2020, 291, 113230-113233; (b) Lei, L.; Huang, X.; Zhang, S.; Yang, J.; Yang, L.; Xu, M., Comparison of prevalence and associated factors of anxiety and depression among people affected by versus people unaffected by quarantine during the COVID-19 epidemic in Southwestern China. Medical science monitor: international medical journal of experimental and clinical research 2020, 26, e924609-1–e924609-12.
34.    Fisher, K. A.; Bloomstone, S. J.; Walder, J.; Crawford, S.; Fouayzi, H.; Mazor, K. M., Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults. Annals of Internal Medicine 2020, 173 (12), 964-973.
35.    Al-Qerem, W. A.; Jarab, A. S., COVID-19 vaccination acceptance and its associated factors among a Middle Eastern population. Frontiers in public health 2021, 9 (632914), 34-45.
36.    (a) Mahase, E., Covid-19: Sore throat, fatigue, and myalgia are more common with new UK variant. BMJ 2021, 372 (288); (b) Murat, S.; Dogruoz Karatekin, B.; Icagasioglu, A.; Ulasoglu, C.; İçten, S.; Incealtin, O., Clinical presentations of pain in patients with COVID-19 infection. Irish Journal of Medical Science (1971-) 2021, 190 (3), 913-917.
37.    (a) Fidan, V., New type of corona virus induced acute otitis media in adult. American journal of otolaryngology 2020, 41 (3), 102487-102492; (b) Philips, C. A.; Mohan, N.; Ahamed, R.; Kumbar, S.; Rajesh, S.; George, T.; Mohanan, M.; Augustine, P., One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World Journal of Clinical Cases 2020, 8 (18), 3956–3970; (c) Wu, P.; Duan, F.; Luo, C.; Liu, Q.; Qu, X.; Liang, L.; Wu, K., Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA ophthalmology 2020, 138 (5), 575-578.
38.    Alaraj, M. (2022). Pharmacological repurposed agents for COVID-19. Research Journal of Pharmacy and Technology, 15(1), 441-446. doi: 10.52711/0974-360X.2022.00073
39.    Dewangan, V.; Sahu, R.; Satapathy, T.; Roy, A., The Exploring of Current Development status and the unusual Symptoms of coronavirus Pandemic (Covid-19). Research journal of Pharmacology and Pharmacodynamics 2020, 12 (4), 172-176.
40.    Jain, R. S., Jain, T. G., & Ishikar, S. K. (2020). Impact of COVID-19 on changing habits and health issues of the public. Asian Journal of Management, 11(4), 524-528. doi: 10.5958/2321-5763.2020.00077.3
41.     (a) Kim, S.; Cho, S. K.; LoCascio, S. P., The role of media use and emotions in risk perception and preventive behaviors related to COVID-19 in South Korea. Asian Journal for Public Opinion Research 2020, 8 (3), 297-323; (b) Wardani, E. M.; Bistara, D. N.; Setiyowati, E., The Influence of Social Media About Covid-19 on Handwashing Behavior, Mask Wearing and Physical Distancing of Indonesian Students. STRADA Jurnal Ilmiah Kesehatan 2020, 9 (2), 1338-1345.
42.    Liu, H.; Wang, L.; Zhao, S.; Kwak-Kim, J.; Mor, G.; Liao, A., Why are pregnant women susceptible 470 to viral infection: an immunological viewpoint. Journal of Reproductive Immunology 2020, 139 (103122).
43.    Yee, M. M., Khaing, M. M., Yee, K. T., & Thidar, A. M. (2022). A brief review on pregnancy risk reasoned to COVID-19. Research Journal of Pharmacy and Technology, 15(1), 424-428. doi: 10.52711/0974-360X.2022.00070
44.    Di Mascio, D.; Khalil, A.; Saccone, G.; Rizzo, G.; Buca, D.; Liberati, M.; Vecchiet, J.; Nappi, L.; Scambia, G.; Berghella, V., Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. American journal of obstetrics and gynecology MFM 2020, 2 (2), 100107-100116.
45.    Ferrazzi, E.; Frigerio, L.; Savasi, V.; Vergani, P.; Prefumo, F.; Barresi, S.; Bianchi, S.; Ciriello, E.; Facchinetti, F.; Gervasi, M. T., Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis. BJOG: An International Journal of Obstetrics and Gynaecology 2020, 127 (9), 1116-1121.
46.    (a) Hapshy, V.; Aziz, D.; Kahar, P.; Khanna, D.; Johnson, K. E.; Parmar, M. S., COVID-19 and pregnancy: risk, symptoms, diagnosis, and treatment. SN comprehensive clinical medicine 2021, 3, 1477-1483; (b) Liao, J.; He, X.; Gong, Q.; Yang, L.; Zhou, C.; Li, J., Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID‐19 pandemic. International Journal of Gynecology and Obstetrics 2020, 150 (1), 53-57.
47.    Victora, C. G.; Bahl, R.; Barros, A. J.; França, G. V.; Horton, S.; Krasevec, J.; Murch, S.; Sankar, M. J.; Walker, N.; Rollins, N. C., Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. The lancet 2016, 387 (10017), 475-490.
48.    Ng, Q. J.; Koh, K. M.; Tagore, S.; Mathur, M., Perception and feelings of antenatal women during Covid-19 pandemic: A cross-sectional survey. Ann. Acad. Med. Singap 2020, 49 (8), 543-552.
49.    Gao, X.; Wang, S.; Zeng, W.; Chen, S.; Wu, J.; Lin, X.; Liu, Y.; Sun, Z.; Feng, L., Clinical and immunologic features among COVID-19–affected mother–infant pairs: antibodies to SARS-CoV-2 detected in breast milk. New Microbes and New Infections 2020, 37, 100752-100760.
50.    Dimopoulou, D.; Triantafyllidou, P.; Daskalaki, A.; Syridou, G.; Papaevangelou, V., Breastfeeding during the novel coronavirus (COVID-19) pandemic: guidelines and challenges. The Journal of Maternal-Fetal and Neonatal Medicine 2020, 1-7.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available